SectorBiological Technology
Established Date26/04/2002
Listing Date29/05/2012
ExchangeNASDAQ Stock Exchange
Full-time Employees31
Fiscal Year Ends31/12
Security TypeCommon stock
Office address11055 Flintkote Avenue, San Diego, California 92121
Business
IntroductionCardiff Oncology, Inc., was incorporated in Florida on April 26, 2002. The company is a clinical-stage biotechnology company that utilizes PLK1 inhibition, a well-proven oncology drug target, to develop new therapies across a range of unmet medical needs for cancer. The company aims to target tumor vulnerability through a therapeutic combination of onvansertib, the company's oral and highly selective PLK1 inhibitors, and standard of care therapies.
